| A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 3 | 2026-10-06 | | NCT06510816 |
|---|
| Clarifying the Optimal Application of SLT Therapy Trial | eye disorder, glaucoma, ocular hypertension | Recruiting | Phase 3 | 2026-08-14 | | NCT04967989 |
|---|
| A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio | Geographic Atrophy Secondary to Age-related Macular Degeneration | Recruiting | Phase 2 | 2026-06-24 | | NCT07215390 |
|---|
| Single-Arm Study of a Treatment for Dry Eye in People Who Struggle to Wear Contact Lenses | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Recruiting | Phase 4 | 2026-04-03 | | NCT07510620 |
|---|
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema | Diabetic Macular Edema (DME) | Active, not recruiting | Phase 2 | 2025-10-30 | | NCT06116916 |
|---|
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration | Neovascular Age-Related Macular Degeneration (nAMD) | Active, not recruiting | Phase 2 | 2025-10-30 | | NCT06116890 |
|---|
| Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™ | Blepharoplasty | Recruiting | Not applicable | 2025-08-27 | | NCT07144761 |
|---|